Endurant Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-73,914
| Closed | -$3.92M | – | 71 |
|
|
2021
Q4 | $3.92M | Buy |
+73,914
| New | +$3.92M | 0.95% | 27 |
|
|
2021
Q3 | – | Sell |
-117,904
| Closed | -$7.86M | – | 56 |
|
|
2021
Q2 | $7.86M | Buy |
117,904
+102,765
| +679% | +$6.85M | 2.16% | 14 |
|
|
2021
Q1 | $1.68M | Buy |
+15,139
| New | +$1.68M | 0.44% | 50 |
|
|
2020
Q4 | – | Sell |
-41,607
| Closed | -$3.63M | – | 63 |
|
|
2020
Q3 | $3.63M | Buy |
41,607
+12,670
| +44% | +$1.11M | 1.07% | 30 |
|
|
2020
Q2 | $2.59M | Buy |
+28,937
| New | +$2.59M | 0.14% | 32 |
|
|
2019
Q4 | – | Sell |
-32,594
| Closed | -$4.11M | – | 57 |
|
|
2019
Q3 | $4.11M | Buy |
+32,594
| New | +$4.11M | 1.48% | 19 |
|
|
2019
Q2 | – | Sell |
-6,691
| Closed | -$585K | – | 63 |
|
|
2019
Q1 | $585K | Buy |
+6,691
| New | +$585K | 0.23% | 56 |
|